Opella Healthcare Poland

Opella Healthcare Poland is the consumer healthcare division of Sanofi, operating as a major provider of over-the-counter (OTC) medicines and health supplements in the Polish market. The company manages a robust portfolio of well-recognized brands, including Allegra, Magne B6, No-Spa, and Essentiale, which address a wide range of consumer needs from allergy relief to digestive health. A key asset of the Polish operations is the manufacturing plant in Rzeszów, which serves as a strategic production hub for various global markets. Opella focuses on therapeutic areas such as pain management, physical and mental wellness, and respiratory care. In 2024, Sanofi announced an agreement to sell a 50% controlling stake in the global Opella business to the private equity firm Clayton, Dubilier & Rice. This transition aims to further strengthen Opella's position as an independent leader in the fast-moving consumer healthcare sector.